Kiniksa Pharmaceuticals International, plc (KNSA) stock
KNSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 14/30473% above fair value
$95.05−0.06 (-0.06%)
Close on Nov 18, 2026Market cap $14.94BP/E 73.1Yield –
Kiniksa Pharmaceuticals International pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Kiniksa Pharmaceuticals International's pe ratio was 98.7× on Nov 11, 2026, against 94.5× a year earlier. Over the last 3 years it ranged from 4.1× to 970.8×, with a median of 76.9×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 98.7× | +7.1 |
| 2025 | Dec 31, 2025 | 91.7× | −240.8 |
| 2024 | Jul 31, 2024 | 332.5× | +327.8 |
| 2023 | Oct 31, 2023 | 4.7× | −2.8 |
| 2022 | Dec 30, 2022 | 7.5× | – |
See a number that looks wrong?